Concepedia

Ivan Hemeon

IH

Statistics

Publications

11

Citations

447

H-Index

11

Active since

2000

Affiliations

Xenon Pharmaceuticals (Canada)(Current)

Saint Mary's University

Shanghai Zhangjiang Laboratory

Albert Einstein College of Medicine

Yeshiva University

Ivan Hemeon is an author at Xenon Pharmaceuticals (Canada) specializing in chemistry, engineering, and organic chemistry.

Top concepts

Publications per year

2000–2021

11

Publications

11

Growth and Metastases of Human Lung Cancer Are Inhibited in Mouse Xenografts by a Transition State Analogue of 5′-Methylthioadenosine Phosphorylase

Indranil Basu, Joseph Locker, María B. Cassera et al. · Journal of Biological Chemistry · 2010 · 79 citations · Full text

1-Ethyl-3-methylimidazolium halogenoaluminate ionic liquids as reaction media for the acylative cleavage of ethers

Laine Green, Ivan Hemeon, Robert D. Singer · Tetrahedron Letters · 2000 · 76 citations

, , +8

Discovery of Aryl Sulfonamides as Isoform-Selective Inhibitors of Na<sub>V</sub>1.7 with Efficacy in Rodent Pain Models

Thilo Focken, Shifeng Liu, Navjot Chahal et al. · ACS Medicinal Chemistry Letters · 2016 · 71 citations · Full text

, , +19

Characterizing DNA Methyltransferases With An Ultrasensitive Luciferase-Linked Continuous Assay

Ivan Hemeon, Jemy A. Gutierrez, Meng-Chiao Ho et al. · Analytical Chemistry · 2011 · 42 citations

, , +13

Discovery of Acyl-sulfonamide Na<sub>v</sub>1.7 Inhibitors GDC-0276 and GDC-0310

Brian S. Safina, Steven J. McKerrall, Shaoyi Sun et al. · Journal of Medicinal Chemistry · 2021 · 35 citations · Full text

1–5 of 11